APS treatments resulted in a significant decrease of Bax protein expression and a significant increase of Bcl-2 protein expression in mitochondria (Bax 2.20 ± 0.38 vs 1.78 ± 0.22; P < 0.05. This evidence concerns the gene BCL2 and autoimmune polyendocrinopathy.